Generic Viagra Challenges the Brand Name Viagra

The medication that has become a household name to treat erectile dysfunction was originally designed and developed to treat pulmonary arterial disease (PAD). Viagra first came to the consumer market in 1998, after approval by the Food and Drug Administration (FDA) and has dominated the erectile dysfunction treatment market ever since. Viagra has become the name for treatment for erectile dysfunction.

The Viagra Australia pills brand name carries a hefty price tag. The cost of the diamond shaped blue pills is directly proportional to the cost to research, develop, advertise, market and deliver an unknown product to the consumer market. Brand name Viagra has been quite successful with its campaign to bring help for erectile dysfunction to men. Because of the marketing effort, the word Viagra has become synonymous with erectile dysfunction and treatment.

Every brand name drug sparks the development of similar generic drugs that are less costly to develop and are made available at a less expensive cost. Viagra brand name is an ideal example of competition from a variety of generic but similar drugs and how the consumer market is driven.

Generic based drugs are required to contain the same active ingredient as the brand name, but additional ingredients can vary. Developing a generic drug eliminates a lot of research that is time consuming and costly. This is because developing a generic drug is not reinventing the wheel. The developers of the brand name Viagra have already completed a great deal of the research and marketing. Generic brand Viagra just has to ride the coattails of a known and what has become a very recognizable medication and capture some of the success by default.

Generic brand Viagra has managed to capture some of the market share from Viagra online, but has not managed to escape some of the negative notions that come along with generic drugs. It is safe to assume generic Viagra has captured enough of the overall erectile dysfunction treatment market to make the brand name sit up and take notice. The toughest hurtle for generic brand medications is to grab enough of the market share with a positive experience with the product to help convince others it is a viable product worth using.

It is also safe to assume that when the patent that fully protects the brand name of Viagra expires, the erectile dysfunction treatment market will be deluged with generic Viagra alternatives and will create a level of competition usually not seen in the medication market. Right now, there is no legal form of generic Viagra available in some parts of the world, but once the patent expires, the door to the erectile dysfunction market will fly open and off the hinges and many generic brands will be waiting for FDA approval which will only add to the competition. The byproduct to the competition will be the cost decrease that competition brings. More vendors will have the opportunity to offer an erectile dysfunction medication bringing the medication to a greater audience.

Social tagging: > >

Leave a Reply